ROBIN HOWARD W (President & CEO) sold 0.6% of their position (444.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $29.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2026ACC: 0001193125-26-235027
DirectorOfficer· President & CEO
Since Aug 2018
-444.00
Net shares
Net seller
$29.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
444.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−444.00
Price / share
$65.51
Trade value
$29.09K
% of position
0.6%
5/19/2026
75.49K→75.05K
Total
Net shares
−444.00
Net value
-$29.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2026 | S · Sale | −444.00 | $65.51 | $29.09K | 0.6% | 75.49K | 75.05K |
| Total | −444.00 | -$29.09K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned28.00
Total
28.00 indirect28.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Total | 28.00 | 28.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported